SCHEMBL6604029

SCHEMBL6604029

C=CCOc1cc([C]=O)cc(C(=O)OC)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.43
BLM P54132 1/20 0.41
RAB9A P51151 3/20 0.41
NPC1 O15118 3/20 0.41
POLB P06746 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ADRB2 P07550 2/20 0.39
ADRB1 P08588 2/20 0.39
ADRB3 P13945 2/20 0.39
KAT6A Q92794 2/20 0.39
ALDH1A1 P00352 1/20 0.38
CHRNB2 P17787 3/20 0.38
CHRNB4 P30926 3/20 0.38
CHRNA3 P32297 3/20 0.38
CHRNA4 P43681 3/20 0.38
FFAR1 O14842 1/20 0.38
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5225682 0.89 MAPT (0.43) MAPTBLMRAB9ANPC1POLB
SCHEMBL644117 0.87 MAPT (0.44) MAPTBLMRAB9ANPC1POLB
SCHEMBL20395893 0.87 MAPT (0.44) MAPTBLMRAB9ANPC1POLB
Hydrogen Sulfide SCHEMBL20395882 0.85 MAPT (0.43) MAPTBLMRAB9ANPC1POLB
SCHEMBL644523 0.82 CA1 (0.43) MAPTBLMRAB9ANPC1POLB
SCHEMBL4878299 0.81 KAT6A (0.51) MAPTBLMRAB9ANPC1POLB
SCHEMBL642424 0.81 CA12 (0.56) MAPTBLMRAB9ANPC1POLB
SCHEMBL2525888 0.81 FFAR1 (0.45) MAPTBLMRAB9ANPC1POLB
SCHEMBL2527989 0.81 CREBBP (0.41) MAPTBLMRAB9ANPC1POLB
SCHEMBL5228091 0.80 ADRB2 (0.40) MAPTBLMRAB9ANPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1332959-C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists NPS PHARMA INC (US) 2007-08-22 CN disclosed
CN-1649865-A Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists NPS PHARMA INC (US) 2005-08-03 CN disclosed
EP-1379525-A2 HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS NPS PHARMACEUTICALS, INC. (US) 2004-01-14 EP disclosed
WO-2002068417-A2 HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS NPS PHARMACEUTICALS, INC. (US) 2002-09-06 WO disclosed